July 3, 2025

PRESS RELEASE Professor Dressler Receives Honorary Professorship from the Tashkent Medical Academy in Uzbekistan 

Professor Dr Dr Dirk Dressler, Head of the Movement Disorders Section at Hannover Medical School, Hannover, Germany, has been awarded an honorary professorship by Tashkent Medical Academy in Uzbekistan for his contributions to the development of botulinum toxin therapy and his research into dystonia. The award ceremony was held by the Rector of Tashkent Medical…

Show this Post ›
June 18, 2025

Annual Meeting of the Boston Scientific Foundation Europe

End of June the annual meeting of the Boston Scientific Foundation Europe  (BSFE) was held in the Boston Scientific offices in Milan, Italy. BSFE helps communities improve their health and well-being by supporting innovative digital health solutions. The Foundation was established in 2018 with the aim of having an immediate and lasting impact by supporting European non-profit organisations….

Show this Post ›
June 17, 2025

Dr. Ahmet Kaymak receives the David Marsden Award 2025

Our congratulations to Dr. Ahmet Kaymak, from the BioRobotics Institute of Scuola Superiore Sant’Anna in Italy who has been selected as winner of the David Marsden Award 2025 for his paper: Spiking Patterns in the Globus Pallidus Highlight Convergent Neural Dynamics across Diverse Genetic Dystonia Syndromes Edwige Ponseel, President of Dystonia Europe said “The Dystonia…

Show this Post ›
June 5, 2025

Getting the right care: Physiotherapy for dystonia in the UK

Physiotherapy is an important part of dystonia management, with research demonstrating it can enhance botulinum toxin injection outcomes, helping reduce pain and improving daily functioning. However, in the UK, whilst neurological physiotherapy is recommended in national pathways, patient access remains unclear. Previous research has highlighted challenges in physiotherapy access for dystonia patients, with many only referred if…

Show this Post ›